Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-12

Clinical Trial Update: Does Serum Procalcitonin Levels Predict Sepsis in Patients Undergoing Cytoreductive Surgery

View source ↗

Summary

A completed study evaluated whether serum procalcitonin levels can predict sepsis in patients undergoing cytoreductive surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Eastern Regional Medical Center | Conditions: Cytoreductive Surgery | Status: COMPLETED